Auto-inflammatory Fever Syndromes

Rheumatic Disease Clinics of North America

Volumn 33, Issue 3, 2007, Pages 585-623

  Padeh, Shai ^a,b   Berkun, Yakov ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; AZATHIOPRINE; BETAMETHASONE; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETANERCEPT; GLUCOCORTICOID; IMMUNOGLOBULIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; PROSTAGLANDIN SYNTHASE INHIBITOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIMVASTATIN; STANOZOLOL; THALIDOMIDE;

ACUTE SCROTUM; AMYLOIDOSIS; APHTHOUS STOMATITIS; ARTHROPATHY; AUTOINFLAMMATORY DISEASE; AUTOINFLAMMATORY FEVER SYNDROME; CINCA SYNDROME; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GASTROINTESTINAL SYMPTOM; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERIMMUNOGLOBULINEMIA; INFLAMMATION; LABORATORY DIAGNOSIS; LACTOSE INTOLERANCE; LYMPHADENOPATHY; MORBIDITY; MUCKLE WELLS SYNDROME; MYALGIA; NAUSEA; OSTEOMYELITIS; PAPA SYNDROME; PATHOPHYSIOLOGY; PERICARDITIS; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; VASCULITIS;

EID: 34948911483     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.07.009     Document Type: Review

References (142)

1. Touitou I. INFEVERS: the repertory of Familial Mediterranean Fever (FMF) and hereditary autoinflammatory disorders mutations. Available at: http://fmf.igh.cnrs.fr/infevers. Accessed July 10, 2007.
2. Kastner D.L., and O'Shea J.J. A fever gene comes in from the cold. Nat Genet 29 (2001) 241
3. Joost P.H., Drenth J.P., van der Meer J.W., et al. The inflammasome-a linebacker of innate defense. N Engl J Med 355 (2006) 730-732
4. Stehlik C., and Reed J.C. The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med 200 (2004) 551-558
5. Liepinsh E., Barbals R., Dahl E., et al. The death-domain fold of the ASC PYRIN domain: presenting a basis for PYRIN/PYRIN recognition. J Mol Biol 332 (2003) 1155-1163
6. Pras M. Familial Mediterranean fever: from clinical syndrome to the cloning of the Pyrin gene. Scand J Rheumatol 27 (1998) 92-97
7. Miceli-Richard C., Lesage S., Rybojad M., et al. CARD15 mutations in Blau syndrome. Nat Genet 29 (2001) 19-29
8. Sohar E., Gafhi J., Pras M., et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43 (1967) 227-253
9. La Regina M.N.G., Diaco M., Procopio A., et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 12 (2004) 85-86
10. Konstantopoulos K., Kanta A., Deltas C., et al. Familial Mediterranean fever associated pyrin mutations in Greece. Ann Rheum Dis 62 (2003) 479-481
11. Kotone-Miyahara Y.T., T-Kondo A., Fukunaga K., et al. E148Q/M694I mutation in 3 Japanese patients with familial Mediterranean fever. Int J Hematol 79 (2004) 235-237
12. Heller H., Sohar E., Kariv I., et al. Familial Mediterranean fever. Harefuah 48 (1955) 91-94
13. Cattan R., and Mamou H. 14 cas de Maladie periodique de dont 8 compliques de nephropathies. Semaine Hop Paris 28 (1952) 1062-1070
14. Retmann H.A., Moadie J., SemerdJian S., et al. Periodic peritonitis-heredity and pathology. Report of seventy-two cases. JAMA 154 (1954) 1254-1259
15. Sohar E., Pras M., Heller J., et al. Genetics of familial Mediterranean fever. Arch Intern Med 7 (1961) 529-538
16. Heller H., GJ, Michaeli D., et al. The arthritis of familial Mediterranean fever (FMF). Arthritis Rheum 9 (1966) 1
17. Goldfinger S.E. Colchicine for familial Mediterranean fever. N Engl J Med 287 (1972) 1302
18. Zemer D., Revah M., Pras M., et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291 (1974) 932-944
19. Pras E., Aksentijevich I., Gruberg L., et al. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 329 (1992) 1509-1513
20. Consortium. TIF. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90 (1997) 797-807
21. Consortium. TFF. A candidate gene for familial Mediterranean fever. Nat Genet 17 (1997) 25-31
22. Berkun Y., Ben-Chirit E., Klar A., et al. Peritoneal adhesions and intestinal obstructions in patients with familial Mediterranean fever-are they more frequent?. Semin Arthritis Rheum 36 (2007) 316-321
23. Rabinovitch O., Zemer D., Kukia E., et al. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol 28 (1992) 245-246
24. Majeed H.A., Ghandour K., and Shahin H.M. The acute scrotum in Arab children with familial Mediterranean fever. Pediatr Surg Int 16 (2000) 72-74
25. Kees S., Langevitz P., Zemer D., et al. Tel Aviv: pericarditis as a rare manifestation of familial Mediterranean fever (FMF). In: Sohar E., Gafni J., and Pras M. (Eds). Familial Mediterranean fever (1997), Freund Publishing House, Tel Aviv, Israel 129-131
26. Sneh E., Pras M., Michaeli D., et al. Protracted arthritis in familial Mediterranean fever. Rheumatol Rehabil 16 (1977) 102-106
27. Salai M., Langevitz P., Blankstein A., et al. Total hip replacement in familial Mediterranean fever. Bull Hosp Jt Dis 53 (1993) 5-28
28. Langevitz P., Zemer D., Livneh A., et al. Protracted febrile myalgia in patients with familial Mediterranean fever. Rheumatology 21 (1994) 1708-1709
29. Azizi E., and Fisher B. Cutaneous manifestations of familial Mediterranean fever. Arch Dermatol 1-2 (1976) 364-366
30. Barzilai A., Langevitz P., Goldberg I., et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 42 (2000) 791-795
31. Pras E., Livneh A., Balow J.E., et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am Med Genet 75 (1998) 216-219
32. Schlesinger M., Rubinow A., and Vardy P.A. Henoch-Schonlein purpura and familial Mediterranean fever. Isr J Med Sci 21 (1985) 83-85
33. Sachs D., Langevitz P., Morag B., et al. Polyarteritis nodosa in familial Mediterranean fever. Br J Rheumatol 26 (1987) 139-141
34. Said R., Hamzeh Y., Said S., et al. Spectrum of renal involvement in familial Mediterranean fever. Kidney Int 41 (1992) 414-419
35. Oner A., Erdogan O., Demircin G., et al. Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever. Pediatr Nephrol 18 (2003) 521-526
36. Lachman H.J., Goodman H.J., Gilbertson J.A., et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356 23 (2007) 2361-2371
37. Goldbach-Mansky R., Dailey N., Canna S.W., et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin 1-beta inhibitor. N Engl J Med 355 (2006) 581-592
38. Gillmore J.D., Lovat L., Persey M.R., et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358 (2001) 24-29
39. Niel Elisabeth, and Scherrman J.M. Colchicine today. Joint Bone Spine 73 (2006) 672-678
40. Lidar M., Scherrman J., Shinar Y., et al. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 33 (2004) 273-282
41. Tufan A., Babaoglu M., Akdogan A., et al. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol 34 (2007) 1-5
42. Fradkin A., Yahav J., Zemer D., et al. Colchicine-induced lactose malabsorption in patients with familial Mediterranean fever. Isr J Med Sci 31 (1995) 616-620
43. Ben-Chetrit E., and Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 62 (2003) 916-919
44. Ehrenfeld M., Brzezinski A., Levy M., et al. Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy. Br J Obstet Gynaecol 94 (1987) 1186-1191
45. Lidar M., Kedem R., Langevitz P., et al. Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine. J Rheumatol 30 (2003) 2620-2623
46. Tunca M., Tankurt E., Akbaylar Akpinar H., et al. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study. Br J Rheumatol 36 (1997) 1005-1008
47. Mor A., Pillinger M., Kishimoto M., et al. Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 13 (2007) 38-40
48. Sakallioglu O., Duzova A., and Ozen S. Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever. Clin Exp Rheumatol 24 (2006) 435-437
49. Seyahi E., Ozdogan H., Masatlioglu S., et al. Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient. Clin Exp Rheumatol 20 (2002) s43-s44
50. Berkun Y., Padeh S., Reichman B., et al. A single testing of serum amyloid A levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. Semin Arthritis Rheum (2007) [Epub ahead of print]
51. Cazeneuve C., Sarkisian T., Pecheux C., et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65 (1999) 88
52. Shohat M., Magal N., Shohat T., et al. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 7 (1999) 287
53. Ozen S., Uckan D., Baskin E., et al. Increased neutrophil apoptosis during attacks of familial Mediterranean fever. Clin Exp Rheumatol 19 (2001) S68
54. Kiraz S., Ertenli I., Ozturk M.A., et al. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis. J Rheumatol 30 (2003) 313
55. Manji G., Wang L., Geddes B., et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 277 (2002) 11570
56. Guijarro C., and Egido J. Transcription factor-kappa B (Nf-kappa B) and renal disease. Kidney Int 59 (2001) 415
57. Ray A., and Ray B. Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF, Nf-kappa B, and C/Ebp transcription factors. J Immunol 163 (1999) 2143
58. Lawrence T., Gilroy G., Colville-Nash P.R., et al. Possible new role for NF-kappa B in the resolution of inflammation. Nat Med 7 12 (2001) 1291-1297
59. Livneh A., Langevitz P., Shinar Y., et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6 (1999) 1
60. Shinar Y., Livneh A., Villa Y., et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun 4 (2003) 197
61. Rabinovich E., Shinar Y., Leiba M., et al. Common FMF alleles may predispose to development of Behçet's disease with increased risk for venous thrombosis. Scand J Rheumatol 36 (2007) 48
62. Koné-Paut I., Sanchez E., Le Quellec A., et al. Autoinflammatory gene mutations in Behçet's disease. Ann Rheum Dis 66 (2007) 832
63. Padeh S., Shinar Y., Pras E., et al. Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever. J Rheumatol 30 (2003) 185
64. Brik R., Riva M., Shinaw M., et al. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 103 (1999) 1025
65. Shinar Y., Livneh A., Langevitz P., et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 27 (2000) 1703
66. Kone Paut I., Dubuc M., Sportouch J., et al. Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of mucocutaneous features. Rheumatology 39 (2000) 1275
67. Dewalle M., Domingo C., Rozenbaum M., et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever. Eur J Hum Genet 6 (1998) 95
68. Aldea A., Campistol J., Arostegui J.I., et al. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV associated periodic inflammatory disorder?. Am J Med Genet 127A (2004) 67-73
69. Booth D.R., Gillmore J., Lachmann H.J., et al. The genetic basis of autosomal dominant familial Mediterranean fever. Q J Med 93 (2000) 217
70. Topaloglu R., Ozaltin F., Yilmaz E., et al. E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever. Ann Rheum Dis 64 (2005) 750-752
71. Tchernitchko D., Legendre M., Cazeneuve C., et al. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 22 (2003) 339-340
72. Livneh A., Aksentijevich I., Langevitz P., et al. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). Eur J Hum Genet 9 (2001) 191
73. Thomas K.T., Feder H., Lawton A.R., et al. Periodic fever syndrome in children. J Pediatr 135 (1999) 15
74. Padeh S., Brezniak N., Zemer D., et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 135 (1999) 98
75. Knockaert D.C., Vanneste L., and Bobbaers H.J. Recurrent or episodic fever of unknown origin: review of 45 cases and survey of the literature. Medicine (Baltimore) 72 (1993) 184
76. Dode C., LeDu N., Cuisset L., et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet 70 (2002) 1498
77. Miller L.C., Sisson B., Tucker L.B., et al. Prolonged fevers of unknown origin in children: patterns of presentation and outcome. J Pediatr 129 (1996) 419
78. Marshall G.S., Edwards K., Butler J., et al. Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 110 (1987) 43
79. Marshall G.S., and Edwards K.M. PFAPA syndrome. [letter]. Pediatr Infect Dis J 8 (1989) 658
80. Takao Y., Toshihiko I., Kentaro Y., et al. Potential use of procalcitonin concentrations as a diagnostic marker of the PFAPA syndrome. Eur J Pediatr 166 (2007) 621
81. Cabral D.A., and Tucker L. Malignancies in children who initially present with rheumatic complaints. J Pediatr 134 (1999) 53
82. Rosen F.S., Cooper M., and Wedgewood R.J.P. The primary immunodeficiencies. [medical progress]. N Engl J Med 333 (1995) 31
83. Shyur S.-D., and Hill H. Immunodeficiency in the 1990s. Pediatr Infect Dis J 10 (1991) 595
84. DiSanto J.P., Bonnefoy Y., Gauchat J.F., et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 541
85. Grimbacher B., Holland S., Gallin J.I., et al. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N Engl J Med 340 (1999) 692
86. Yang K., and Hill H. Assessment of neutrophil function disorders: practical and preventive interventions. Pediatr Infect Dis J 13 (1994) 906
87. Grose C., Schnetzer J., Ferrante A., et al. Children with hyperimmunoglobulinemia D and periodic fever syndrome. Pediatr Infect Dis J 15 (1996) 72
88. Tasher D., Somekh E., and Dalal I. PFAPA syndrome: new clinical aspects disclosed. Arch Dis Child 91 (2006) 981
89. Ridder G.J., Fradis M., Berner R., et al. [PFAPA syndrome: current standard of knowledge and relevance for the ENT specialist]. Laryngorhinootologie 81 (2002) 635 [in German]
90. Saulsbury F.T., and Wispelwey B. Tumor necrosis factor receptor-associated periodic syndrome in a young adult who had features of periodic fever, aphthous stomatitis, pharyngitis, and adenitis as a child. J Pediatr 146 (2005) 283
91. Feder H.M. Cimetidine treatment for periodic fever associated with aphthous stomatitis, pharyngitis, and cervical adenitis. Pediatr Infect Dis J 11 (1992) 318
92. Abramson J.S., Givner L., and Thompson J.N. Possible role of tonsillectomy and adenoidectomy in children with recurrent fever and tonsillopharyngitis. Pediatr Infect Dis J 8 (1989) 119
93. Wright D.G., Dale D., Fauci A.S., et al. Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore) 60 (1981) 1
94. Dale D.C., and Hammond W. Cyclic neutropenia: a clinical review. Blood Rev 2 (1988) 178
95. Engervall P., Andersson B., and Bjorkholm M. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol 91 (1995) 838
96. Horwitz M., Benson K., Person R.E., et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 23 (1999) 433
97. Stojanov S., Hoffman F., Kéry A., et al. Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw 17 2 (2006) 90-97
98. Long S.S. Syndrome of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA)-what it isn't. What is it?. J Pediatr 135 (1999) 1
99. Williamson L.M., Hull D., Mehta R., et al. Familial Hibernian fever. Q J Med 51 (1982) 469
100. McDermott M.F., Aksentijevich I., Galon J., et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97 (1999) 133
101. Derre J., Kemper O., Cherif D., et al. The gene for the type 1 tumor necrosis factor receptor (TNF-R1) is localized on band 12p13. Hum Genet 87 (1991) 231
102. Smith C.A., Davis T., Anderson D., et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248 (1990) 1019
103. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 334 (1996) 1717
104. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10 (1992) 411-452
105. Drewe E., Powell P., Isaacs J.D., et al. Prospective study of anti-tumor necrosis factor superfamily 1a and 1b fusion proteins in tumor necrosis factor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of six patients. Rheumatology (Oxford) 42 (2003) 235
106. Hull K.M., Drewe E., Aksentijevich I., et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81 (2002) 349
107. Simon A., Bodar E., Van der Hist J.G., et al. Beneficial response to interleukin 1 receptor antagonistin TRAPS. Am J Med 117 (2004) 208
108. Todd I., Radford P., Draper-Morgan K.A., et al. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signaling functions but show abnormal behaviour. Immunology 113 (2004) 65
109. Siebert S., Amos N., Fielding C.A., et al. Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum 52 (2005) 1287
110. Van der Meer J.W.M., Vossen J., Radl J., et al. Hyperimmunoglobulinemia D and periodic fever: a new syndrome. Lancet (1984) 1087
111. Reeves W.G., and Mitchell J. Hyperimmunoglobulinemia D and periodic fever. Lancet (1984) 1463
112. Scolozzi R., Boccafogli A., and Vicentini L. Hyper-IgD syndrome and other hereditary periodic fever syndromes. Reumatismo 56 (2004) 147
113. Prieur A.M., and Griscelli C. Nosologic aspects of systemic forms of very early onset juvenile arthritis. Apropos of 17 cases. Ann Pediatr (Paris) 30 (1983) 565
114. Drenth J.P.H., and Powell R. Hyperimmunoglobulinemia D syndrome: conference. Lancet 345 (1995) 445
115. Drenth J.P., Cuisset L., Grateau G., et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22 (1999) 178
116. McDermott M., Ogunkolade B., McDermott E.M., et al. Linkage of familial Hibernian fever to chromosome 12p13. Am J Hum Genet 62 (1998) 1446
117. Drenth H.C.J.P., and van der Meer J. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 73 (1994) 133
118. Drenth J.P., Boom B., Toonstra J., et al. Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. Arch Dermatol 130 (1994) 59
119. Livneh A., Drenth J., Klasen I.S., et al. Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features. Rheumatology 24 (1997) 1558
120. Drenth J.P., Vonk A., Simon A., et al. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 298 (2001) 1221
121. Simon A., Drewe E., van der Meer J.W., et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75 (2004) 476
122. Demirkaya E., Calgar M., Waterham H.R., et al. A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clin Rheumatol 26 10 (2007) 1757-1759
123. Takada K., Aksentijevich I., Mahadevan V., et al. Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 48 (2003) 2645
124. Cailliez M.G.F., Rousset-Rouvière C., Bruno D., et al. Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis 29 (2006) 763
125. Neven B., Valayannopoulos V., Quartier P., et al. Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med 356 (2007) 2700
126. Edwards P.A., and Ericsson J. Sterols and isoprenoids signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68 (1999) 157
127. Nagashima T., Okazaki H., Yudoh K., et al. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. Arthritis Rheum 54 (2006) 579
128. Hoffmann G.F., Charpentier C., Mayatepek E., et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 91 (1993) 915
129. Bodar E.J., van der Hilst J., van Heerde W., et al. Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome. Blood 109 (2007) 2416
130. Kastner D.L., and Aksentijevich I. Intermittent and periodic arthritis syndromes. In: Koopman W.J., and Moreland L.W. (Eds). Arthritis and allied conditions. 15th edition (2005), Lippincott Williams and Wilkins, Philadelphia 1411-1461
131. Hoffman H., Mueller J., Broide D., et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29 (2001) 301
132. Aksentijevich I., Nowak M., Mallah M., et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 46 (2002) 3340
133. Feldmann J., Prieur A.-M., Quartier P., et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71 (2002) 198
134. Frenkel J., Wulffraat N., and Kuis W. Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins, et al and Hoffman and Patel. Arthritis Rheum 50 (2004) 3738
135. Prieur A.M., Griscelli C., Lambert F., et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol 66 Suppl (1987) 57
136. Prieur A.M. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 19 (2001) 103
137. Leone V., Presani G., Perticarari S., et al. Chronic infantile neurological cutaneous articular syndrome: CD10 over-expression in neutrophils is a possible key to the pathogenesis of the disease. Eur J Pediatr 162 (2003) 669
138. Hawkins P.N., Lachmann H., Aganna E., et al. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50 (2004) 607
139. Derbes V.J., and Coleman W. Familial cold urticaria. Ann Allergy 30 (1972) 335
140. Porksen G., Lohse P., Rosen-Wolff A., et al. Periodic fever, mild arthralgias, and reversible moderate and severe organ inflammation associated with the V198M mutation in the CIAS1 gene in three German patients-expanding phenotype of CIAS1 related autoinflammatory syndrome. Eur J Haematol 73 (2004) 123
141. Ormerod A.D., Smart L., Reid T.M.S., et al. Familial cold urticaria: investigation of a family and response to stanozolol. Arch Dermatol 129 (1993) 343
142. Al-Mosawi Z.S., Al-Saad K.K., Ijadi-Maghsoodi R., et al. A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum 56 3 (2007) 960-964